ROYAL BANK OF CANADA - ACUMEN PHARMACEUTICALS INC ownership

ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 68 filers reported holding ACUMEN PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ACUMEN PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$10,0004,045
+3865.7%
0.00%
Q1 2024$0
-100.0%
102
-84.7%
0.00%
Q4 2023$2,000668
+554.9%
0.00%
Q3 2023$0
-100.0%
102
-65.5%
0.00%
Q2 2023$1,000
-50.0%
296
-22.9%
0.00%
Q1 2023$2,000384
+7580.0%
0.00%
Q4 2022$0
-100.0%
5
-90.2%
0.00%
Q3 2022$1,000
-85.7%
51
-97.1%
0.00%
Q1 2022$7,000
-56.2%
1,739
-26.6%
0.00%
Q4 2021$16,0000.0%2,370
+115.3%
0.00%
Q3 2021$16,0001,1010.00%
Other shareholders
ACUMEN PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$13,121,5683.65%
Knollwood Investment Advisory, LLC 1,628,510$6,253,4781.30%
RA Capital Management 14,932,063$57,339,1220.90%
Parkman Healthcare Partners LLC 603,497$2,317,4280.33%
Rock Springs Capital Management LP 2,300,059$8,832,2270.22%
Ikarian Capital, LLC 315,265$1,210,6170.11%
CATALYST FINANCIAL PARTNERS LLC 89,699$344,4440.10%
TANG CAPITAL MANAGEMENT LLC 246,895$948,0770.09%
Laurion Capital Management LP 1,895,023$7,276,8880.06%
Intrepid Financial Planning Group LLC 30,150$115,7760.06%
View complete list of ACUMEN PHARMACEUTICALS INC shareholders